follow us
disclaim warranti liabil
due number sourc inform servic acquisdata pti ltd servic obtain
inher hazard electron distribut may delay omiss inaccuraci inform
servic acquisdata pti ltd affili agent sale repres distributor licensor
warrant accuraci complet current merchant abil fit particular purpos
inform servic avail acquisdata pti ltd servic event acquisdata pti ltd
affili agent sale repres distributor licensor liabl license anyon els loss
injuri caus whole part conting beyond control procur compil interpret edit write
report deliv inform servic acquisdata pti ltd servic event acquisdata
pti ltd affili agent sale repres distributor licensor liabl license anyon els
decis made action taken license relianc upon inform servic consequenti
special similar damag even advis possibl damag license agre liabil
acquisdata pti ltd affili agent sale repres distributor licensor aris kind
legal claim whether contract tort otherwis way connect acquisdata pti ltd servic shall
exceed amount license paid use acquisdata pti ltd servic twelv month immedi
preced event give rise claim
abbott park ill juli /prnewswire/ -- abbott nyse today announc financi result
second-quart world-wide sale billion increas percent report basi percent
report dilut ep continu oper second quarter
adjust dilut ep continu oper exclud specifi item abbott
abbott rais full-year ep guidanc rang continu reflect strong double-digit growth
abbott project full-year dilut ep continu oper basi project full-
year adjust dilut ep continu oper
may abbott receiv approv fda xienc sierra newest gener gold-
standard coronari stent system offer design technolog advanc provid easier implant
greater abil treat complex blockag second quarter xienc sierra also receiv nation
reimburs japan treat peopl coronari arteri diseas
may abbott announc fda clearanc advisor hd grid map cathet sensor enabl
creat highli detail map heart expand abbott lead electrophysiolog product portfolio
juli abbott receiv fda approv next-gener version lead mitraclip heart valv repair
devic new version includ design advanc simplifi minim invas procedur enabl
patient treat mitraclip
four busi exceed expect contribut strong growth overal said mile white
chairman chief execut offic abbott forecast continu strong perform rais full-year
note manag believ measur sale growth rate organ basi appropri way
investor best understand underli perform busi
exclud prior year result abbott medic optic amo st jude medic vascular closur busi
divest first quarter
exclud current prior year result rapid diagnost reflect result aler inc
acquir oct
exclud impact foreign exchang
world-wide nutrit sale increas percent report basi second quarter includ favor
percent effect foreign exchang increas percent organ basi
world-wide pediatr nutrit sale increas percent report basi second quarter includ
favor percent effect foreign exchang increas percent organ basi sale
increas percent report basi includ favor percent effect foreign exchang
increas percent organ basi strong perform quarter led growth sever countri
across asia includ greater china latin america
world-wide adult nutrit sale increas percent report basi second quarter includ favor
percent effect foreign exchang increas percent organ basi sale increas
percent report basi includ favor percent effect foreign exchang increas
percent organ basi sale perform led strong growth ensur abbott market-lead
complet balanc nutrit brand glucerna abbott market-lead diabetes-specif nutrit brand
world-wide diagnost sale increas percent report basi second quarter organ basi
sale increas percent refer tabl titl non-gaap reconcili adjust histor revenu
reconcili adjust histor revenu
laboratori diagnost sale increas percent report basi second quarter includ
favor percent effect foreign exchang increas percent organ basi growth
quarter driven continu share gain global
molecular diagnost sale increas percent report basi second quarter includ favor
percent effect foreign exchang increas percent organ basi world-wide sale led
strong growth infecti diseas test abbott core area focu molecular diagnost market
partial off-set plan scale test area primarili
point diagnost sale decreas percent report basi second quarter includ
favor percent effect foreign exchang decreas percent organ basi
rapid diagnost world-wide sale million led infecti diseas cardiometabol test
establish pharmaceut sale increas percent report basi second quarter includ
unfavor percent effect foreign exchang increas percent organ basi
emerg market compris sever countri repres attract long-term growth opportun
abbott brand gener product portfolio sale geographi increas percent report basi
second quarter includ unfavor percent effect foreign exchang increas percent
organ basi sale growth led double-digit growth across sever geographi includ india china
world-wide medic devic sale increas percent report basi second quarter organ
basi sale increas percent refer tabl titl non-gaap reconcili adjust histor revenu
reconcili adjust histor revenu
cardiovascular neuromodul sale growth quarter led double-digit growth electrophysiolog
structur heart
electrophysiolog growth led strong perform cardiac map ablat well share gain
recent launch abbott confirm rx insert cardiac monitor icm world first
smartphone-compat icm design help physician remot identifi cardiac arrhythmia may abbott
announc fda clearanc advisor hd grid map cathet sensor enabl creat highli detail
map heart expand abbott lead electrophysiolog product portfolio
vascular second quarter abbott receiv approv fda xienc sierra newest
gener gold-standard coronari stent system offer design technolog advanc provid
easier implant greater abil treat complex blockag quarter xienc sierra also receiv
nation reimburs japan treat peopl coronari arteri diseas
growth structur heart driven sever product area across abbott broad portfolio includ
amplatz pfo occlud mitraclip abbott market-lead devic minim invas treatment
mitral regurgit juli abbott announc fda approv next-gener version mitraclip
enhanc design provid even greater precis accuraci
diabet sale increas percent report basi percent organ basi
growth led continu rapid market uptak freestyl libr abbott revolutionari sensor-bas
continu glucos monitor cgm system remov need routin peopl
abbott project dilut earn per share continu oper gener accept account
principl
abbott forecast net specifi item full year approxim per share specifi item includ
intang amort expens acquisition-rel expens charg associ cost reduct initi
expens
exclud specifi item project adjust dilut earn per share continu oper would
full year
abbott issu third-quart guidanc dilut earn per share continu oper
abbott forecast specifi item third quarter primarili relat intang
amort acquisition-rel expens cost reduct initi expens exclud specifi item
project adjust dilut earn per share continu oper would third
june board director abbott declar compani quarterli dividend per share
abbott cash dividend payabl aug sharehold record close busi juli
abbott increas dividend pay-out consecut year member dividend
aristocrat index track compani annual increas dividend least consecut
acquisdata proud host leagu estim want opportun win free
subscript join acquisdata media telecommun leagu
abbott global diversifi healthcar compani central purpos help peopl live healthiest possibl
live offer broad portfolio market-lead product align favor long-term healthcar trend
develop develop market build strong foundat year success abbott
pois deliv top-tier growth expand margin strong cash flow increas return sharehold
acquisdata date busi intellig report cover develop world
report vast archiv corpor document list compani around world
januari found global biopharmaceut compani focu capabl
address world greatest health challeng stabil resourc expertis passion
discov develop bring market groundbreak scienc solv biggest health problem face
world today tomorrow
one world lead biotechnolog compani values-bas compani deepli root
scienc innov transform new idea discoveri medicin patient seriou ill
commit unlock potenti biolog patient suffer seriou ill discov
develop manufactur deliv innov human therapeut approach begin use tool like
advanc human genet unravel complex diseas understand fundament human biolog
baxter touch million live everi day product servic essenti build block healthcar
youll find baxter product therapi nearli everi floor everi depart almost everi hospit
world-wide youll find us clinic home
bristol-my squibb global biopharma compani firmli focus mission discov develop deliv
innov medicin help patient prevail seriou diseas bristol-my squibb uk aim deliv
commit patient custom employe commun environ
compani nyse
compani found colonel eli lilli man commit creat high-qual medicin
meet real need centuri later passion build preced continu
pursuit make life better individu commun world around us
found year ago genentech lead biotechnolog compani discov develop
manufactur commerci medicin treat patient seriou life-threaten medic condit
compani member roch group headquart south san francisco california
johnson johnson nyse
johnson johnson famili compani engag research develop manufactur
sale broad rang product health care field virtual countri world johnson
johnson primari interest histor current product relat human health well-
johnson johnson incorpor state new jersey
unit state us popul million peopl embodi one complex health care
system world intertwin relationship provid payer patient receiv care
histor day us health care system constant state evolut trail behind china
india us third popul countri world spend trillion health care
gross domest product switzerland unit kingdom spent
respect health care growth health care spend mostli attribut growth
pharmaceut drug devic sinc attribut growth per year
depart human servic hh feder level primari agenc respons
regul health care system us state certain degre self-govern also
depart doh implement state-level health polici care provis financ
serv formerli serv militari independ manag either depart defens dod
depart veteran affair va two depart financ total health expenditur
health care sector multi-pay system compos public privat financ sourc public health
insur scheme oper center medicar medicaid servic medicar medicaid
children health insur program chip financ primarili govern tax medicar
largest singl payer us provid health care coverag age year older -- regardless
incom medic histori -- age perman disabl end-stag renal diseas
medicaid jointli fund feder govern individu state state set
guidelin regard elig servic reimburs medicaid provid care individu poverti
level afford pay health care given elig chip nation health insur
program children year age elig insur plan includ privat insur
privat financ sourc consist privat health insur plan out-of-pocket payment individu
insur via public privat plan sever nation health insur plan well region
self-insur plan organ larg compani us common employ contribut privat
insur premium either whole part employe individu also buy privat health insur
privat insur collect premium individu employ turn pay
provid hospit physician health servic accord contract provid
individu neither cover public health insur scheme privat health plan pay out-of pocket
point servic moreov individu health insur respons pay co-pay insur
provid complet coverag total out-of-pocket spend billion out-of-pocket
cost insur patient retail medicin alon billion
public privat hospit except special veteran facil receiv payment
public privat financ sourc hospit typic paid base diagnost relat group drg
payment drg wide use mani privat payer payment scheme hospit drg-
base payment cover accommod cost hospit room board facil cost etc procedur cost
support staff nurs technician etc drug/med devic cost howev system includ
physician fee drug reimburs inpati drg though especi expens
innov drug paid separ outpati drg call ambulatori payment classif apc
drg payment rate updat per year base standard payment drg region wage
differ region cost live differ type health care provid taken account
calcul final payment procedur use variou index inform drg payment
found websit
privat insur pay hospit basi drg case rate per-diem fee-for-servic discount fee-for-
servic scheme averag payment exceed hospit cost provid underli servic
theori margin built payment cover loss hospit may serv uninsur
care servic provid commun hospital-bas health care profession solo-pract self-
employ gener practition physician may employ hospit medic group either privat
affili hospit typic locat within larg teach hospit increas number primari care
practic purchas hospit physician becom hospit employe ambulatori
secondari tertiari care provid hospital-bas doctor either self- hospital-employ
nation hospit mix public privat though privat hospit mostli not-for profit domin
number public hospit typic large-s tertiari teach hospit
individu may choos health care provid base coverag particular health insur plan
exampl health mainten organ hmo plan provid health insur health care servic
enrolle howev individu restrict health care servic provid avail within
hmo network similarli prefer provid organ ppo plan contract specif health care provid
restrict access contract physician enrolle ppo insur option treat
non-contract provid would need pay significantli out-of-pocket sinc provid consid out-
physician self-employ paid fee-for-servic patient cover public
health insur scheme medicar medicaid chip price health care servic defin
base either physician fee schedul medicaid price procedur
conduct physician calcul base nation uniform rel valu unit rvu point given
procedur region cost per unit privat insur also pay self-employ physician base
physician fee schedul howev differ rate negoti physician privat insur
us health care system reli heavili privat sector character lack univers health
care insur case differ develop countri patient protect afford act hr
sign law march allow greater access health care particularli among
uninsur bill phase sever year aim chang us health care system system
almost univers access health insur start octob open enrol began health insur
market place full summari afford act found henri kaiser famili
new law make mandatori employ employ fulltim employe provid health
insur coverag full-tim employe otherwis face financi penalti likewis citizen except
low incom expect enrol form health insur els face penalti law
expand elig medicaid allow peopl insur could afford insur
previous abl buy tax-pay subsid coverag diagram health coverag afford
act kaiser famili foundat identifi options/avail health care coverag addit new
law make illeg insur compani refus coverag peopl pre-exist medic condit
stop coverag becom ill
intern societi pharmacoeconom outcom researh
acquisdata date busi intellig report cover develop world
report vast archiv corpor document list compani around world
